SCHEMBL7702402

SCHEMBL7702402

CN1CCCN(CCCOc2cccc(-c3n[nH]c4c3Cc3ccccc3-4)c2)CC1

nearest known ligand 0.63

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDR P35968 10/20 0.63
CHEK1 O14757 8/20 0.58
ADORA3 P0DMS8 2/20 0.48
ADORA2A P29274 2/20 0.48
ADORA2B P29275 2/20 0.48
ADORA1 P30542 2/20 0.48
HRH3 Q9Y5N1 2/20 0.48
DRD2 P14416 1/20 0.48
DRD3 P35462 1/20 0.48
AURKA O14965 1/20 0.47
CHEK2 O96017 1/20 0.47
LCK P06239 1/20 0.47
CSF1R P07333 1/20 0.47
FGFR1 P11362 1/20 0.47
MARK3 P27448 1/20 0.47
FLT3 P36888 1/20 0.47
ITK Q08881 1/20 0.47
MARK2 Q7KZI7 1/20 0.47
AURKB Q96GD4 1/20 0.47
KCNH2 Q12809 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7700924 0.96 KDR (0.67) KDRCHEK1AURKACHEK2LCK
SCHEMBL7140591 0.95 KDR (0.64) KDRCHEK1MARK3FLT3MARK2
SCHEMBL7703663 0.94 CHEK1 (0.62) KDRCHEK1ADORA3ADORA2AADORA2B
SCHEMBL7147004 0.92 KDR (0.68) KDRCHEK1CSF1RMARK3FLT3
SCHEMBL7702307 0.89 KDR (0.54) KDRCHEK1ADORA3ADORA2AADORA2B
SCHEMBL7702517 0.89 KDR (0.57) KDRCHEK1AURKACHEK2LCK
SCHEMBL7147015 0.89 KDR (0.59) KDRCHEK1ADORA3ADORA2AADORA2B
SCHEMBL7703429 0.88 CHEK1 (0.63) KDRCHEK1MARK3FLT3MARK2
SCHEMBL7703072 0.85 KDR (0.55) KDRCHEK1MARK3FLT3MARK2
SCHEMBL7172093 0.84 KDR (0.58) KDRCHEK1MARK3FLT3MARK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6462036-B1 INHIBITING SIGNAL TRANSDUCTION BY MODULATING ACTIVITY OF RECEPTOR AND NONRECEPTOR TYROSINE AND SERINE/THREONINE KINASES TO REGULATE AND MODULATE ABNORMAL OR INAPPROPRIATE CELL PROLIFERATION, DIFFERENTIATION, OR METABOLISM BASF AKTIENGESELLSCHAFT (DE) 2002-10-08 US disclosed